Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology

Autor: Frederick R. Appelbaum, Keith W. Pratz, Steven Coutre, Dale L. Bixby, Michael Gary Martin, Steven D. Gore, Melanie Fiorella, William Blum, Richard Stone, Deniz Peker, Martin S. Tallman, Daniel A. Pollyea, Farhad Ravandi, Camille N. Abboud, Vijaya Raj Bhatt, Jeffrey E. Lancet, Rebecca L. Olin, Matthew J. Wieduwilt, Stephen A. Strickland, Lori J. Maness, Daniel A. Arber, James M. Foran, Aric C. Hall, Guido Marcucci, Patricia Kropf, Eunice S. Wang, Paul J. Shami, Amir T. Fathi, Kristina M. Gregory, Ndiya Ogba, Jessica K. Altman, Marcos de Lima, Joseph O. Moore, Margaret R. O'Donnell
Rok vydání: 2017
Předmět:
Zdroj: Journal of the National Comprehensive Cancer Network. 15:926-957
ISSN: 1540-1413
1540-1405
DOI: 10.6004/jnccn.2017.0116
Popis: Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age
Databáze: OpenAIRE